Literature DB >> 16877184

Monitoring symptoms in patients with advanced illness in long-term care: A pilot study.

John R Brechtl1, Shaiqua Murshed, Peter Homel, Marilyn Bookbinder.   

Abstract

The Edmonton Symptom Assessment Scale (ESAS) was administered daily by nursing staff in a long-term care facility (LTCF) to monitor symptoms. Scores greater than or equal to 5 on a 0-10 scale were considered moderate-to-severe and triggered prompt treatment. One hundred and eight patients with advanced illness and perceived prognosis of less than 6 months were identified for rapid symptom management over a 7-month period. Forty-six (43%) of these patients had at least one episode of moderate-to-severe symptoms during the follow-up period. Thirty-one of these patients (67%) had a primary diagnosis of advanced AIDS and 12 (26%) had advanced cancer. Pain was the most frequent of the 15 symptoms measured, occurring in 29 patients. In the case of pain (P = 0.001), tiredness (P = 0.004), and well-being (P = 0.003), rapid symptom management led to significantly improved distress scores within 48 hours. These data suggest that it is feasible for nurses in an LTCF to use the ESAS on a daily basis to assess patients and obtain prompt treatment for distressful symptoms. Rapid treatment of symptoms can be an important quality indicator in nursing home patients with advanced illness.

Entities:  

Mesh:

Year:  2006        PMID: 16877184     DOI: 10.1016/j.jpainsymman.2006.02.012

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  10 in total

1.  Health care providers' use and knowledge of the Edmonton Symptom Assessment System (ESAS): is there a need to improve information and training?

Authors:  Daniela Carli Buttenschoen; Jarad Stephan; Sharon Watanabe; Cheryl Nekolaichuk
Journal:  Support Care Cancer       Date:  2013-09-13       Impact factor: 3.603

2.  Effect on Symptom Management Education Receiving Patients of Chemotherapy.

Authors:  Zümrüt Akgün Şahin; Seher Ergüney
Journal:  J Cancer Educ       Date:  2016-03       Impact factor: 2.037

3.  Wound outcomes in patients with advanced illness.

Authors:  Vincent Maida; Marguerite Ennis; Jason Corban
Journal:  Int Wound J       Date:  2012-02-02       Impact factor: 3.315

4.  A new palliative care consultation team at the oncology department of a university hospital: an assessment of initial efficiency and effectiveness.

Authors:  Ana de Santiago; María Angustias Portela; Luis Ramos; Ana Larumbe; Julia Urdiroz; Marina Martínez; Jesús García-Foncillas; Carlos Centeno
Journal:  Support Care Cancer       Date:  2012-05-03       Impact factor: 3.603

5.  Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes.

Authors:  Dagmar Abelone Dalin; Sara Frandsen; Gitte Krogh Madsen; Charlotte Vermehren
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-21

6.  Needs of developing the skills of palliative care at the oncology ward: an audit of symptoms among 203 consecutive cancer patients in Finland.

Authors:  E Salminen; K E Clemens; K Syrjänen; H Salmenoja
Journal:  Support Care Cancer       Date:  2007-04-26       Impact factor: 3.603

Review 7.  Pain and symptom management in palliative care and at end of life.

Authors:  Diana J Wilkie; Miriam O Ezenwa
Journal:  Nurs Outlook       Date:  2012-09-14       Impact factor: 3.250

8.  Wounds in advanced illness: a prevalence and incidence study based on a prospective case series.

Authors:  Vincent Maida; Mario Corbo; Michael Dolzhykov; Marguerite Ennis; Shiraz Irani; Linda Trozzolo
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

9.  A review of the reliability and validity of the Edmonton Symptom Assessment System.

Authors:  L A Richardson; G W Jones
Journal:  Curr Oncol       Date:  2009-01       Impact factor: 3.677

10.  Prevalence of distressing symptoms in hospitalised patients on medical wards: A cross-sectional study.

Authors:  Katrin Ruth Sigurdardottir; Dagny Faksvåg Haugen
Journal:  BMC Palliat Care       Date:  2008-09-23       Impact factor: 3.234

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.